BioPharma Credit (LON:BPCP) Reaches New 12-Month High – Should You Buy?

BioPharma Credit PLC (LON:BPCPGet Free Report) shares reached a new 52-week high on Wednesday . The company traded as high as GBX 74 and last traded at GBX 74, with a volume of 71636 shares. The stock had previously closed at GBX 72.30.

BioPharma Credit Stock Down 1.3%

The company’s fifty day moving average is GBX 71.33 and its two-hundred day moving average is GBX 69.93. The firm has a market capitalization of £980.05 million, a price-to-earnings ratio of 10.54 and a beta of 0.18.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

See Also

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.